SCHEMBL30833003

SCHEMBL30833003

CCOc1cc(C)c(-c2ccccc2)c(C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 5/20 0.49
PPARG P37231 1/20 0.48
PPARA Q07869 1/20 0.48
LTA4H P09960 1/20 0.47
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46
HPGD P15428 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KDM4E B2RXH2 2/20 0.45
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
TP53 P04637 2/20 0.45
RAB9A P51151 2/20 0.45
RELA Q04206 2/20 0.43
TTK P33981 1/20 0.43
BRD4 O60885 1/20 0.43
BRD2 P25440 1/20 0.43
CREBBP Q92793 1/20 0.43
NQO1 P15559 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30832999 0.86 FFAR1 (0.45) FFAR1PPARGPPARALTA4HCNR1
SCHEMBL18757057 0.85 FFAR1 (0.40) FFAR1PPARGPPARALTA4HCNR1
SCHEMBL30833001 0.85 FFAR1 (0.49) FFAR1PPARGPPARALTA4HMAPT
SCHEMBL30833000 0.84 FFAR1 (0.55) FFAR1PPARGPPARA
SCHEMBL23309025 0.84 FFAR1 (0.49) FFAR1HPGDSMN1; SMN2KDM4EALDH1A1
SCHEMBL16575393 0.81 ADORA3 (0.49) LTA4HCNR1CNR2GPR55HPGD
SCHEMBL30833002 0.80 FFAR1 (0.50) FFAR1PPARGPPARAKDM4EALDH1A1
SCHEMBL10682048 0.79 KCNA3 (0.44) FFAR1PPARGPPARA
SCHEMBL10676207 0.78 CYP3A4 (0.49) FFAR1PPARGPPARAHPGDSMN1; SMN2
SCHEMBL28166768 0.78 RXRA (0.53) LTA4HHPGDSMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11905230-B2 Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament CHINA PHARMACEUTICAL UNIVERSITY (CN) 2024-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11905230-B2 Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament SLC5A1, PYGL, GPR119 FFAR1 57/4885PPARG 39/4885PPARA 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.